发明名称 IMIDAZOPYRIDIN-2-ONE DERIVATIVE
摘要 <p>Disclosed is a prophylactic and/or therapeutic agent for rejection after transplant surgery and for diseases caused by immune system abnormalities, comprising a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In general formula (I), A represents a 8- to 10-membered partially saturated or aromatic fused bicycylic nitrogen-containing heterocyclic group having 1 to 3 nitrogen atoms; A may have the same or different n R1's as substituents; n represents an integer of 0 to 3; B represents a 3- to 7-membered saturated or partially saturated monocyclic hydrocarbon group and may contain 1 or 2 oxygen atoms, sulfur atoms, nitrogen atoms, sulfinyl groups or sulfonyl groups as ring constituents; B may have the same or different m R2's as substituents; R2 represents a substituent present on a carbon atom or a nitrogen atom which forms B; and Q represents a bond or a C1-4 alkylene group.</p>
申请公布号 WO2011096490(A1) 申请公布日期 2011.08.11
申请号 WO2011JP52278 申请日期 2011.02.03
申请人 DAIICHI SANKYO COMPANY,LIMITED;OHTSUKA, MASAMI;HAGINOYA, NORIYASU;ICHIKAWA, MASANORI;MATSUNAGA, HIRONORI;SAITO, HIRONAO;SHIBATA, YOSHIHIRO;TSUNEMI, TOMOYUKI 发明人 OHTSUKA, MASAMI;HAGINOYA, NORIYASU;ICHIKAWA, MASANORI;MATSUNAGA, HIRONORI;SAITO, HIRONAO;SHIBATA, YOSHIHIRO;TSUNEMI, TOMOYUKI
分类号 A61P3/10;C07D471/04;A61K31/437;A61P1/04;A61P1/16;A61P5/00;A61P7/00;A61P7/06;A61P11/00;A61P11/02;A61P13/00;A61P13/12;A61P15/00;A61P17/00;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P21/04;A61P25/00;A61P27/02;A61P37/06;A61P37/08;A61P43/00;C07D519/00 主分类号 A61P3/10
代理机构 代理人
主权项
地址